Helps lower elevated triglycerides and, when added to statin therapy in appropriate patients, reduces the risk of major cardiovascular events.
In secondary prevention, purified EPA has been shown to reduce the risk of recurrent cardiac events in people with a history of heart disease.
Modulates the inflammatory and lipid pathways involved in atherosclerosis, complementing standard cholesterol management for long-term protection.
Icosapent ethyl is a highly purified form of eicosapentaenoic acid (EPA), an omega-3 fatty acid. It helps lower elevated triglycerides and, in landmark cardiovascular outcomes research, has been shown to reduce the risk of major cardiovascular events in appropriately selected patients already on statin therapy. It works through anti-inflammatory and lipid-modifying pathways that complement standard cholesterol management.
Pharmaceutical products are only available to members of the Lifeforce Membership ($149/month) and are contingent on blood tests results and clinician video consult. To qualify for the program you must reside in an eligible state* and purchase a Lifeforce Diagnostic ($599).

Reduce the production of “bad” cholesterol in the liver.

Support healthy cholesterol levels with this FDA-approved medication that works by reducing the absorption of cholesterol on the small intestine.

An ACE inhibitor that helps support optimal blood pressure and can protect the heart and kidneys.

A long-acting calcium channel blocker that supports healthy blood pressure and helps reduce the risk of cardiovascular events.